Key result
High levels of soluble CD40L independently predicted the risk of cardiovascular events in patients with asymptomatic low-grade carotid stenosis over a median follow-up of 8 years.
Why the study?
Do high levels of soluble CD40L predict the risk of cardiovascular events in patients with asymptomatic low-grade carotid stenosis?
Cohort (n=63)
Do high levels of soluble CD40L predict the risk of cardiovascular events in patients with asymptomatic low-grade carotid stenosis?
Elevated soluble CD40L levels may serve as an independent biomarker for predicting future cardiovascular events in patients with asymptomatic low-grade carotid stenosis.
Answers are grounded in this paper and cite their sources.
May support soluble CD40L as a biomarker in asymptomatic low-grade carotid stenosis; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND AND PURPOSE: We investigated whether soluble CD40L (sCD40L) may predict the risk of cardiovascular (CV) events in patients with asymptomatic carotid plaques. METHODS: Forty-two patients with asymptomatic low-grade carotid stenosis (ALCS) and 21 controls without any carotid stenosis were enrolled. All subjects had at least a major cardiovascular risk factor (CRF). Plasma levels of C-reactive protein (CRP), IL-6, and sCD40L were measured. Subjects were reviewed every 12 months (median follow-up, 8 years). RESULTS: ALCS patients had higher (P<0.0001) CRP, IL-6, and sCD40L than controls. Fourteen patients experienced a CV event. Cox regression analysis showed that only high sCD40L levels (P=0.003) independently predicted cardiovascular risk. CONCLUSIONS: High levels of sCD40L may predict the risk of CV events in ALCS.
No takes yet. Share an insight, caveat, or question.
Novo et al. (2005) conducted a cohort in Asymptomatic low-grade carotid stenosis (n=63). High soluble CD40L (sCD40L) levels vs. Low sCD40L levels was evaluated on Cardiovascular events (p=0.003). High levels of soluble CD40L independently predicted the risk of cardiovascular events in patients with asymptomatic low-grade carotid stenosis over a median follow-up of 8 years.
Synapse has enriched 10 related papers. Consider them for comparative context: